Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market

Genomenon, Inc., and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China.

Genomenon’s Mastermind is the leading genomic search engine on the market. With nearly 3,500 users in over 100 countries, Mastermind has become the search engine of choice when researching patient variants for clinical NGS interpretation. Dozens of clinical labs in North America and Europe have standardized on Mastermind in their NGS workflow to improve diagnostic yield and reduce turn around times. The partnership with Shanghai Shanyi aims to improve the quality of genetic disease diagnosis and treatment decisions in China.

“We’re very excited about this partnership”, says Mike Klein, Chief Executive Officer at Genomenon. “Our partnership with Shanghai Shanyi will allow us to expand our footprint in the China market, seamlessly integrating with their other best-of-breed end-to-end clinical NGS solutions.”

“We’re proud to bring Mastermind to clinical laboratories in China” said Lei Li, GM at Shanghai Shanyi. “In the early work we’ve done with customers, they’ve been able to reduce their time spent researching variants of uncertain significance (VUS’s) by 60 to 80%, reducing the biggest bottleneck labs face in diagnosing genetic diseases and generating patient reports.”

About Genomenon

Genomenon connects patient DNA with the billions of dollars spent on research to help doctors diagnose and cure cancer patients and babies with rare diseases.

Our flagship product, the Mastermind Genomic Search Engine is used by hundreds of genetic labs worldwide to accelerate diagnosis, increase diagnostic yield and assure repeatability in reporting genetic testing results.

We license our Mastermind Curated Genomic Datasets to pharmaceutical and bio-pharma companies to inform precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence.

About Shanghai Shanyi Biological Technology Co., Ltd

Shanghai Shanyi is a leading provider of molecular technology service and solutions, including NGS interpretation, variant validation services, DNA Extraction solutions, dedicated in improving the molecular medical service quality in China.

Partners include: Genomenon, LifeMap, Illumina, Geneyx

Customers include: Novogene, Genergy, BGI, Fudan University, Peiking Union Hospital, Beijing Children Hospital, Shanghai Children Medical Center, Ruijing Hospital, Western China Hospital, Guangxi Maternal Hospital, Shenzhen Maternal Hospital, Guangdong Maternal Hospital.

< | >